Chimeric Therapeutics Ensures Compliance Amid Late Lodgement
Company Announcements

Chimeric Therapeutics Ensures Compliance Amid Late Lodgement

Chimeric Therapeutics Ltd. (AU:CHM) has released an update.

Chimeric Therapeutics Ltd. reported a late lodgement of Form 604 due to changes in substantial holdings caused by share dilution. The company stressed this as an isolated incident and assured its compliance with ASX regulations, while considering improved compliance monitoring. Investors might see this as a crucial step in maintaining transparency and regulatory adherence.

For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App